2016-01696. National Cancer Institute; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Omnibus SEP-8.

    Date: March 11, 2016.

    Time: 8:00 a.m. to 5:00 p.m.

    Agenda: To review and evaluate grant applications.

    Place: Bethesda North Marriott Hotel and Conference Center, 5701 Marinelli Road, Room Brookside A&B, North Bethesda, MD 20852.

    Contact Person: Jennifer C. Schiltz, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W634, Rockville, MD 20850, 240-276-5864, jennifer.schiltz@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Omnibus SEP-11A.

    Date: March 21, 2016.

    Time: 10:00 a.m. to 5:00 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W602 Rockville, MD 20850, (Telephone Conference Call).

    Contact Person: Delia Tang, MD, Scientific Review Officer, Research Programs, Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W602, Bethesda, MD 20892, 240-276-6456, tangd@mail.nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

    Start Signature

    Dated: January 25, 2016.

    Melanie J. Gray,

    Program Analyst, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2016-01696 Filed 1-28-16; 8:45 am]

    BILLING CODE 4140-01-P

Document Information

Effective Date:
3/11/2016
Published:
01/29/2016
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
2016-01696
Dates:
March 11, 2016.
Pages:
5016-5016 (1 pages)
PDF File:
2016-01696.pdf